Sign in
CompletedNo phase

Letrozole in Oligospermia With Eugonadotropic-Hypogonadism and Low Testosterone Estradiol Ratio

Key facts

Who runs it
Mst.Sumyara Khatun
Where
Bangladesh1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
60 people enrolled
Started
1 Jul 2023
Ended
31 Dec 2024
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Tab.Letrozole 2.5 mg once daily for 3 months
  • Tab.Placebo once daily for 3 months
Record updated
6 November 2026

Who can take part

Age
20 years to 45 years
Sex
Men only
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 10 criteriaShow less

Who can take part

  • Infertile male
  • Age 20 -45 years,
  • Oligospermia (sperm count < 10 million/ml) or azoospermia with low serum testosterone (<300 ng/dl), normal gonadotropin level (FSH, LH 2-7 IU/L), and low (<10:1) testosterone to estradiol ratio

Who cannot take part

  • Previous chemotherapy or radiotherapy
  • Concomitant use of anticonvulsants
  • Antioxidant supplements in the previous 3 months
  • Medical and endocrine disorders
  • Genital diseases \& genital surgery
  • Alcohol or substance abuse
  • Androgens or antiandrogen

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

The goal of this clinical trial is to learn if drug letrozole works to treat oligospermia in adults. It will also learn about the safety of drug letrozole. The main questions it aims to answer are:

Read full original descriptionShow less

Does drug letrozole improves semen parameter, serum restosterone, testosterone estradiol ratio in male with oligospermia.

What medical problems do participants have when taking drug letrozole? Researchers will compare drug letrozole to a placebo (a look-alike substance that contains no drug) to see if drug letrozole works to treat oligospermia..

Participants will:

Take drug letrozole or a placebo once daily for 3 months Visit the clinic three months after treatment

The 2 groups in the trial

  • Experimental group:Letrozole 2.5 mg once daily for 3 monthsTreatment being tested

    Tab.Letrozole 2.5 mg once daily for 3 months

    Treatment: Tab.Letrozole 2.5 mg once daily for 3 months

  • Comparator group: Placebo once daily for 3 monthsExisting treatment, for comparison

    Tab.Placebo once daily for 3 months

    Treatment: Tab.Placebo once daily for 3 months

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
6 November 2026